Dupont Releases Clinical Study Results Demonstrating Benefits Of High-Potency And Multi-Strain Probiotic Formulations

Nutrients journal publishes new study suggesting higher doses of a DuPont multispecies probiotic formulation may permit more benefits for healthy adults

- 

Results of a clinical trial performed by Tavernitiand colleagues from the University of Milan (IT) suggest that ingesting higher doses of multispecies probiotic formulations may permit higher, earlier and longer recovery of probiotics in feces of healthy adults.

The aim of the study, published in the journal Nutrients, was to understand the effect of bacterial count on the transient colonisation in the human intestinal tract of four different DuPont probiotic strains administered in a single, commercially available, formulation. The four DuPont strains under investigation were: Bifidobacterium lactis Bl-04, Lactobacillus acidophilus La-14, Lactobacillus plantarum SDZ-11 and Lactobacillus paracasei SDZ-22. The study compared the formulation at two different doses–seven billion and 70 billion colony forming units (CFU), with the goal of measuring cell recovery in faeces after oral administration.